Jiong Li

1.7k total citations · 1 hit paper
32 papers, 1.1k citations indexed

About

Jiong Li is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Jiong Li has authored 32 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 11 papers in Oncology and 5 papers in Cell Biology. Recurrent topics in Jiong Li's work include Cancer-related gene regulation (7 papers), Wnt/β-catenin signaling in development and cancer (6 papers) and Protein Degradation and Inhibitors (5 papers). Jiong Li is often cited by papers focused on Cancer-related gene regulation (7 papers), Wnt/β-catenin signaling in development and cancer (6 papers) and Protein Degradation and Inhibitors (5 papers). Jiong Li collaborates with scholars based in United States, China and Sweden. Jiong Li's co-authors include Cun‐Yu Wang, D. S. Parker, Ken M. Cadigan, Gh Rasool Bhat, Yongxin Yu, Jin Koo Kim, Yang Li, Paul H. Krebsbach, Lingfei Jia and Wuchang Zhang and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and The EMBO Journal.

In The Last Decade

Jiong Li

32 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

CD276 expression enables squamous cell carcinoma stem cells to evade immune surveillance

2021 204 citations Cheng Wang, Yang Li et al. Cell stem cell profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jiong Li United States	16	815	313	250	195	122	32	1.1k
Jesse L. Cox United States	18	677 0.8×	362 1.2×	197 0.8×	147 0.8×	101 0.8×	50	1.1k
Lizhou Jia China	19	468 0.6×	433 1.4×	265 1.1×	224 1.1×	123 1.0×	45	968
Gabriel J. Villares United States	18	666 0.8×	330 1.1×	271 1.1×	241 1.2×	96 0.8×	19	1.2k
Minhong Shen China	16	643 0.8×	370 1.2×	243 1.0×	207 1.1×	93 0.8×	25	1.3k
Mélanie Tichet France	16	674 0.8×	441 1.4×	196 0.8×	303 1.6×	88 0.7×	20	1.1k
Elvin Wagenblast United States	9	589 0.7×	434 1.4×	301 1.2×	98 0.5×	97 0.8×	21	923
Yuan Mao China	20	497 0.6×	445 1.4×	152 0.6×	266 1.4×	123 1.0×	58	946
Yuhki Yokoyama Japan	18	1.1k 1.4×	561 1.8×	259 1.0×	196 1.0×	176 1.4×	46	1.6k
Hyung‐Gyoon Kim United States	17	541 0.7×	405 1.3×	189 0.8×	197 1.0×	134 1.1×	33	1.0k
Soufiane Boumahdi United States	4	836 1.0×	560 1.8×	356 1.4×	132 0.7×	147 1.2×	4	1.2k

Countries citing papers authored by Jiong Li

Since Specialization

Citations

This map shows the geographic impact of Jiong Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiong Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiong Li more than expected).

Fields of papers citing papers by Jiong Li

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiong Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiong Li. The network helps show where Jiong Li may publish in the future.

Co-authorship network of co-authors of Jiong Li

This figure shows the co-authorship network connecting the top 25 collaborators of Jiong Li. A scholar is included among the top collaborators of Jiong Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiong Li. Jiong Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pagare, Piyusha P., et al.. (2024). Novel PROTAC probes targeting FOSL1 degradation to eliminate head and neck squamous cell carcinoma cancer stem cells. Bioorganic Chemistry. 151. 107613–107613. 4 indexed citations

Ghosh, Chinmoy, Zheng Liu, Chunqing Guo, et al.. (2024). Type I gamma phosphatidylinositol phosphate 5-kinase i5 controls cell sensitivity to interferon. Developmental Cell. 59(8). 1028–1042.e5. 2 indexed citations

Pagare, Piyusha P., et al.. (2024). Novel PROTAC probes targeting KDM3 degradation to eliminate colorectal cancer stem cells through inhibition of Wnt/β-catenin signaling. RSC Medicinal Chemistry. 15(11). 3746–3758. 7 indexed citations

Ren, Junling, et al.. (2023). P. gingivalis Infection Upregulates PD-L1 Expression on Dendritic Cells, Suppresses CD8+ T-cell Responses, and Aggravates Oral Cancer. Cancer Immunology Research. 11(3). 290–305. 30 indexed citations

Kellogg, Glen E., Yana Cen, Maƚgorzata Dukat, et al.. (2023). Merging cultures and disciplines to create a drug discovery ecosystem at Virginia commonwealth university: Medicinal chemistry, structural biology, molecular and behavioral pharmacology and computational chemistry. SLAS DISCOVERY. 28(6). 255–269. 2 indexed citations

Wang, Ganping, Zhikun Ma, Gan Xiong, et al.. (2022). BET inhibition triggers antitumor immunity by enhancing MHC class I expression in head and neck squamous cell carcinoma. Molecular Therapy. 30(11). 3394–3413. 19 indexed citations

Pradhan, Anjan K., Praveen Bhoopathi, Santanu Maji, et al.. (2022). Enhanced Cancer Therapy Using an Engineered Designer Cytokine Alone and in Combination With an Immune Checkpoint Inhibitor. Frontiers in Oncology. 12. 812560–812560. 5 indexed citations

Bhat, Gh Rasool, et al.. (2021). Head and neck cancer: Current challenges and future perspectives. Advances in cancer research. 152. 67–102. 84 indexed citations

Maji, Santanu, Sabindra K. Samal, Jiong Li, et al.. (2021). SARI inhibits growth and reduces survival of oral squamous cell carcinomas (OSCC) by inducing endoplasmic reticulum stress. Life Sciences. 287. 120141–120141. 7 indexed citations

10.

Ghosh, Chinmoy, Yanli Xing, Suhua Li, et al.. (2021). Sorting nexin 6 interacts with Cullin3 and regulates programmed death ligand 1 expression. FEBS Letters. 595(20). 2558–2569. 4 indexed citations

11.

Dong, Jiaqiang, Jiong Li, Yang Li, et al.. (2021). Transcriptional super-enhancers control cancer stemness and metastasis genes in squamous cell carcinoma. Nature Communications. 12(1). 3974–3974. 87 indexed citations

12.

Wang, Cheng, Yang Li, Lingfei Jia, et al.. (2021). CD276 expression enables squamous cell carcinoma stem cells to evade immune surveillance. Cell stem cell. 28(9). 1597–1613.e7. 204 indexed citations breakdown →

13.

Pradhan, Anjan K., Amit Kumar, Sarmistha Talukdar, et al.. (2021). Insights into the Mechanisms of Action of MDA-7/IL-24: A Ubiquitous Cancer-Suppressing Protein. International Journal of Molecular Sciences. 23(1). 72–72. 11 indexed citations

14.

Zhang, Ming, Zhikun Ma, Bo Sun, et al.. (2021). FOSL1 promotes metastasis of head and neck squamous cell carcinoma through super-enhancer-driven transcription program. Molecular Therapy. 29(8). 2583–2600. 71 indexed citations

15.

Yu, Pei, Yue Wu, Haichao Liu, et al.. (2020). MicroRNA-204-5p is a tumor suppressor and potential therapeutic target in head and neck squamous cell carcinoma. Theranostics. 10(3). 1433–1453. 45 indexed citations

16.

Fan, Jiabing, Chung‐Sung Lee, Soyon Kim, et al.. (2020). Trb3 controls mesenchymal stem cell lineage fate and enhances bone regeneration by scaffold-mediated local gene delivery. Biomaterials. 264. 120445–120445. 31 indexed citations

17.

Li, Jiong, Bo Yu, Peng Deng, et al.. (2017). KDM3 epigenetically controls tumorigenic potentials of human colorectal cancer stem cells through Wnt/β-catenin signalling. Nature Communications. 8(1). 15146–15146. 104 indexed citations

18.

Li, Jiong, Christopher Sutter, D. S. Parker, et al.. (2007). CBP/p300 are bimodal regulators of Wnt signaling. The EMBO Journal. 26(9). 2284–2294. 111 indexed citations

19.

He, Qiu-ming, Yuquan Wei, Ling Tian, et al.. (2003). Inhibition of Tumor Growth with a Vaccine Based on Xenogeneic Homologous Fibroblast Growth Factor Receptor-1 in Mice. Journal of Biological Chemistry. 278(24). 21831–21836. 66 indexed citations

20.

Xiang, Di, Jiong Li, Yao Jianming, & Yu Zengliang. (2002). The breeding of Streptomyces spectabilis 1043 by ion beam implantation. Jiguang shengwu xuebao. 11(4). 276–279. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact